从中风临床前评估网络的结果来看,芬戈利莫德是潜在的脑保护剂
Ligia S B Boisserand1, Alison L Herman1, Basavaraju G Sanganahalli2
1Department of Neurology, Yale University School of Medicine, New Haven, CT. (L.S.B.B., A.L.H., H.E.B., C.W.J., J.G., L.H.S.).
Stroke
|September 3, 2025
概括
在临床前模型中,fingolimod没有改善整体中风结果. 然而,它对功能恢复和大脑缩的影响因动物的性别和特定健康状况而异.
科学领域:
- 神经科学
- 免疫学
- 药理学
背景情况:
- 芬戈利莫德是一种免疫调节药物,在中风治疗中具有潜力.
- 它向基酸盐受体,影响淋巴细胞迁移.
- 之前的研究表明神经保护和恢复的好处.
研究的目的:
- 评估fingolimod在中风中的治疗潜力.
- 在临床前中风模型中评估fingolimod对功能和形态结果的影响.
- 根据性别和并发症来分析fingolimod的疗效变化.
主要方法:
- 对中风临床前评估网络 (SPAN) 试验数据的二次分析.
- 使用了4种临床前模型:年轻健康的老年肥胖引起的高血糖小鼠和高血压小鼠.
- 由中脑动脉封闭引起的中风;用fingolimod或载体治疗.
- 通过MRI评估功能结果 (角测试,脚缺陷) 和病变大小/大脑形态测量.
主要成果:
- 总的来说,fingolimod没有改善功能性或形态性中风的结果.
- 根据性别和并发症模型,疗效有所不同.
- 在老年雌性中改善角测试;在肥胖的高血糖小鼠中恶化结果.
- 在老年男性中减弱的中线收缩,表明缩.
结论:
- 这一分析不支持fingolimod在中风中的整体疗效.
- 治疗效果在很大程度上取决于个体患者的特征,如性别和并发症.
- 强调个性化医疗方法在中风治疗中的重要性.
相关概念视频
01:15Ischemic Stroke l: Introduction
44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
01:15Ischemic Stroke ll: Pathophysiology
54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54